Clinical Trials in Pittsburgh

Showing 12041-12060 of 18,076 trials

Pragmatic Airway Resuscitation Trial

NCT02419573

The primary objective of the trial is to determine if 72-hour survival after out-of-hospital cardiac arrest (OHCA) is improved with initial endotracheal intubation (ETI) over initial laryngeal tube (LT) airway management strategies.

Cardiac Arrest

University of Alabama at Birmingham3,004 participantsStarted Dec 2015

Birmingham, Alabama, United States • Portland, Oregon, United States • Pittsburgh, Pennsylvania, United States +3 more locations

TERMINATEDPhase 2< 1 mile

Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's Syndrome

NCT01552681

The purpose of the study is to find out if the experimental study agent, baminercept, is effective in treating patients with Sjögren's syndrome. The study will also determine if the study agent can be safely given to patients with Sjögren's syndrome; examine how it affects symptoms of the disease; and attempt to understand how baminercept affects the underlying mechanisms of Sjögren's syndrome and the immune system.

Primary Sjögren's Syndrome

National Institute of Allergy and Infectious Diseases (NIAID)52 participantsStarted Jul 2012

Los Angeles, California, United States • Palo Alto, California, United States • Hartford, Connecticut, United States +6 more locations

Pragmatic Airway Resuscitation Trial

Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's Syndrome

Find Trials by Condition in Pittsburgh

A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure

A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions

A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease

A Study of Vadastuximab Talirine Given Prior to or After Allogeneic Hematopoietic Stem Cell Transplant in AML Patients

A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC

Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO

Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

Norovirus Bivalent-Vaccine Efficacy Study

Aspen Spinous Process Fixation System for Use in PLF in Patients With Spondylolisthesis

PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB

A Safety Study in Participants With Advanced Solid Tumors

Acceptance Of A Partially-Hydrolyzed Infant Formula

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma

Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII

Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis

Detection of Cytomegalovirus Virus in Neonates